- Home
- PARR vs PCRX Comparison
PARR vs PCRX Comparison
Compare PARR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PARR
- PCRX
- Stock Information
- Founded
- PARR 1984
- PCRX 2006
- Country
- PARR United States
- PCRX United States
- Employees
- PARR N/A
- PCRX N/A
- Industry
- PARR Integrated oil Companies
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- PARR Energy
- PCRX Health Care
- Exchange
- PARR Nasdaq
- PCRX Nasdaq
- Market Cap
- PARR 1.5B
- PCRX 1.2B
- IPO Year
- PARR N/A
- PCRX 2011
- Fundamental
- Price
- PARR $33.61
- PCRX $27.22
- Analyst Decision
- PARR Buy
- PCRX Buy
- Analyst Count
- PARR 6
- PCRX 6
- Target Price
- PARR $27.46
- PCRX $30.00
- AVG Volume (30 Days)
- PARR 1.7M
- PCRX 626.5K
- Earning Date
- PARR 11-03-2025
- PCRX 11-05-2025
- Dividend Yield
- PARR N/A
- PCRX N/A
- EPS Growth
- PARR N/A
- PCRX N/A
- EPS
- PARR N/A
- PCRX N/A
- Revenue
- PARR $7,614,628,000.00
- PCRX $705,848,000.00
- Revenue This Year
- PARR N/A
- PCRX $7.36
- Revenue Next Year
- PARR N/A
- PCRX $10.07
- P/E Ratio
- PARR N/A
- PCRX N/A
- Revenue Growth
- PARR N/A
- PCRX 2.25
- 52 Week Low
- PARR $11.86
- PCRX $12.61
- 52 Week High
- PARR $36.39
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- PARR 54.32
- PCRX 65.07
- Support Level
- PARR $33.14
- PCRX $25.63
- Resistance Level
- PARR $36.39
- PCRX $27.11
- Average True Range (ATR)
- PARR 1.53
- PCRX 0.90
- MACD
- PARR -0.06
- PCRX -0.03
- Stochastic Oscillator
- PARR 46.03
- PCRX 83.00
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.